Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Characteristics of Serum Metabolites and Gut Microbiota in Diabetic Kidney Disease
Bo Zhang, Yuzhou Wan, Xuefeng Zhou, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Chronic kidney disease and gut microbiota
Siamak Amini Khiabani, Mohammad Asgharzadeh, Hossein Samadi Kafil
Heliyon (2023) Vol. 9, Iss. 8, pp. e18991-e18991
Open Access | Times Cited: 29
The roles of gut microbiota and its metabolites in diabetic nephropathy
Hui Zhao, Cheng-E Yang, Tian Liu, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 24
Gut microbiota and its metabolites – molecular mechanisms and management strategies in diabetic kidney disease
Zi‐Hui Mao, Zhong‐Xiuzi Gao, Dongwei Liu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 22
Causal relationship between gut microbiota and diabetic nephropathy: a two-sample Mendelian randomization study
Shuxiang Yan, Hua Wang, Baiyu Feng, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
Transcriptomics and metabolomics analysis reveal the anti-oxidation and immune boosting effects of mulberry leaves in growing mutton sheep
Xiaopeng Cui, Yuxin Yang, Minjuan Zhang, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 20
Lipid metabolism disorder in diabetic kidney disease
Yi-Zhen Han, Bo-Xuan Du, Xingyu Zhu, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 6
Fucoidan Oligosaccharide Supplementation Relieved Kidney Injury and Modulated Intestinal Homeostasis in D-Galactose-Exposed Rats
Jing Shi, Yan Xu, Kening Zhang, et al.
Nutrients (2025) Vol. 17, Iss. 2, pp. 325-325
Open Access
From Clinical to Benchside: Lacticaseibacillus and Faecalibacterium Are Positively Associated With Muscle Health and Alleviate Age‐Related Muscle Disorder
Chaoran Liu, Pui Yan Wong, Nilakshi Barua, et al.
Aging Cell (2025)
Open Access
Cornuside as a promising therapeutic agent for diabetic kidney disease: Targeting regulation of Ca2+ disorder-mediated renal tubular epithelial cells apoptosis
Gai Gao, Xuan Su, Shu-Yan Liu, et al.
International Immunopharmacology (2025) Vol. 149, pp. 114190-114190
Closed Access
Sodium glucose co-transporter 2 (SGLT2) inhibition via dapagliflozin improves diabetic kidney disease (DKD) over time associatied with increasing effect on the gut microbiota in db/db mice
Jiajia Wu, Yan Chen, Huinan Yang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 14
Advancements, Challenges, and clinical implications of integration of metabolomics technologies in diabetic nephropathy
Vijay Sharma, Manoj Khokhar, Prasanta K. Panigrahi, et al.
Clinica Chimica Acta (2024) Vol. 561, pp. 119842-119842
Closed Access | Times Cited: 4
The causal association of specific gut microbiota on the risk of membranous nephropathy: a Mendelian randomization study
Qiqi Ma, Xiaoli Wen, Gaosi Xu
International Urology and Nephrology (2024) Vol. 56, Iss. 6, pp. 2021-2030
Closed Access | Times Cited: 3
Ginsenoside Compound K Ameliorates Development of Diabetic Kidney Disease through Inhibiting TLR4 Activation Induced by Microbially Produced Imidazole Propionate
Qian Chen, Dongwen Ren, Liu Luo-kun, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 12863-12863
Open Access | Times Cited: 15
Construction of a Nomogram-Based Prediction Model for the Risk of Diabetic Kidney Disease in T2DM
Xian Wang, Xiaming Liu, Jun Zhao, et al.
Diabetes Metabolic Syndrome and Obesity (2024) Vol. Volume 17, pp. 215-225
Open Access | Times Cited: 2
The Mineralocorticoid Receptors in diabetic kidney disease
Guanghong Jia, Guido Lastra, Brian P. Bostick, et al.
AJP Renal Physiology (2024) Vol. 327, Iss. 3, pp. F519-F531
Closed Access | Times Cited: 2
Screening for Early Biomarkers of Cisplatin-Induced Acute Kidney Injury in Rats Through Serum Metabolomics Technology
Jinru Yang, Mingkang Zhang, Fenglin Ran, et al.
Journal of College of Physicians And Surgeons Pakistan (2024) Vol. 34, Iss. 08, pp. 936-941
Open Access | Times Cited: 2
Lactobacillus helveticus attenuates alcoholic liver injury via regulation of gut microecology in mice
Jiawen Lv, Guanjing Lang, Qiangqiang Wang, et al.
Microbial Biotechnology (2024) Vol. 17, Iss. 10
Open Access | Times Cited: 2
The potential mechanism of gut microbiota-microbial metabolites-mitochondrial axis in progression of diabetic kidney disease
Leilei Ma, Li Zhang, Jing Li, et al.
Molecular Medicine (2023) Vol. 29, Iss. 1
Open Access | Times Cited: 7
Sacubitril/Valsartan contributes to improving the diabetic kidney disease and regulating the gut microbiota in mice
Peipei Wang, Ruixue Guo, Xiwen Bai, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 11
The role of microbial metabolites in diabetic kidney disease
Ting Zhu, Bi-Ying Hu, Yiqing Zhang, et al.
Heliyon (2023) Vol. 9, Iss. 7, pp. e17844-e17844
Open Access | Times Cited: 5
Gut microbiota microbial metabolites in diabetic nephropathy patients: far to go
Jianxiu Yu, Xin Chen, Su-Gang Zang, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 1
Metabolomic analysis of cooperative adaptation between Co-cultured Lacticaseibacillus casei Zhang and Lactiplantibacillus plantarum P8
Shuai Guo, Bohai Li, Dandan Wang, et al.
LWT (2022) Vol. 170, pp. 114105-114105
Open Access | Times Cited: 8
Intrafollicular fluid metabolic abnormalities in relation to ovarian hyperstimulation syndrome: Follicular fluid metabolomics via gas chromatography-mass spectrometry
Yixuan Sun, Lijuan Hao, Wei Han, et al.
Clinica Chimica Acta (2022) Vol. 538, pp. 189-202
Closed Access | Times Cited: 4
Gut Microbiota and Diabetic Kidney Diseases
Alessandra Stasi, Francesca Conserva, Maria Teresa Cimmarusti, et al.
Endocrinology (2024), pp. 373-394
Closed Access
Gut Microbiota-derived Metabolites: A New Perspective of Traditional Chinese Medicine Against Diabetic Kidney Disease
Hailing Zhao, Tingting Zhao, Ping Li
Integrative Medicine in Nephrology and Andrology (2024) Vol. 11, Iss. 2
Closed Access
Page 1 - Next Page

Scroll to top